Baseline gut microbiome dysbiosis predicts gut microbiome response to ART co-trimoxazole treatment in HIV-positive individuals in rural and urban Zimbabwe - Alessandro Lazzaro, MD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020

Distinct Gene Expression Signatures are Associated with Viral Suppression in Youth with HIV on ART: Implications for Novel Diagnostic or Therapeutic Targets - Samiksha Borkar

Viral Infections & Inflammation Workshop 2023

What are the pros and cons of HBsAg loss as the endpoint for treatment? | Jordan Feld, MD, MPH

International Workshop on HBV Cure 2018

Long term impacts of PrEP – How to reduce toxicity and resistance - Pep Coll, MD

Workshop on Healthy Living with HIV 2020

Towards more affordable HCV therapy - Andrew Hill, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

The pattern of risk compensation in MSM enrolled in a pilot PrEP project- Tsz Ho Kwan

APACC 2018

Cabotegravir for Women - A Potential Game Changer - Nyaradzo Mgodi

International Workshop on HIV & Women 2021

Upscaling Delivery of Pre-Exposure Prophylaxis Among Key Populations in Nigeria: A Case Study of FSWs, MSM and PWUDs in Nigeria.

International Workshop on HIV Transmission 2020

Rational pricing and the role of generics - Raymond Schinazi, PhD, DSc

International Hepatitis Cure & Eradication Meeting 2015

Prevalence and correlates of HIV infection among people who use drugs in Cambodia: results from a national survey

APACC 2019